Trump's management is strongly reducing the high price of Americans in general. It is a short contract that will happen shortly.
On Tuesday, President Donald Trump Signed Executive orders set the procedures that the government through the Department of Health and Human Service is planning to reduce the price of the drug. While some offers But some people shouldn't move the needle Trump's lawyers and GOP are preparing or having other measures that may increase the price of many Americans.
The main plank of the order of executives related to improvement Medicare addiction negotiation project: The BIDEN program that allows the government to negotiate the price that Medicare will pay directly for medication according to the prescription of the most expenses in the market. The first baking negotiations last year and resulting in reduced drugs, although the discount will not work until the year 2026, the second round of negotiations involved in 15 drugs and will summarize this year, with a discount in 2081.
One of the most important drugs in the second round is semaglutide, active ingredients used in drugs, type 2, ok and rrybelsus, as well as obesity drugs. WEGOVY drugs that use semaglutide are higher than $ 1,000 per month, without any rights and patients with highly accessible and lacking names. Therefore, if the price is truly reduced, it will represent the true success. But again, the discount will not arrive until 2028 of the last year of Trump (hoped that) in the presidency of the president. In the meantime, his HHS makes people in Medicare get these drugs more difficult.
Currently, Medicare is not able to cover weight loss drugs directly, although it can provide protection to people who use ozica and similar drugs for diabetes or obesity conditions such as heart disease. Bio management Proposed Last year to quit this restriction and open the coverage for 7 million Americans about Medicare and Medicaid by 2026 at the beginning of this month. However, Trump's management reduce This proposal HHS Robert F. Kennedy Specified Last week, the administration was considering some “frame” to expand, even though the RFK JR himself has Repeat The value of these drugs in the past
Another wrinkles in Trump's plan to reduce drug prices involved in the so -called “drug punishment”. The drug has no right to receive negotiation programs until they are in the market for a period of time. For prescription medical prescriptions, small molecules tend to be this delayed pill now seven years (actually nine years ago, the price will be reduced), but for more complex biological drugs, the drug is generally used by injection-delay is 11 years (13 years).
If David Dayn According to the opportunity and others have noticed the order of the executives, it says that HHS will be shorter, the delay of biology that is eligible to receive programs and the currently supporting of drugs. Expansion The monopoly period of small molecules to match biology. (Solving problems from the Democrats have tried to reduce the time for both).
From the KFF analysis published on Wednesday Four years delay Will delete more than half of the drugs included in the negotiation program to the present, including Semaglutide, stepping forward, the longer monopoly for these drugs will allow the government to save a lot of money and finally attacking many American wallets that rely on them.
In the statement on Wednesday, Wedic Ron Wide (D -oregon), a member of the Senate Finance Committee Controversial Trump's executive order will definitely reduce the reform of the price.
“Like his first term, Trump is all the bark and does not bite when talking about reducing the cost of the medical prescription,” said Widen. “The executive's commands are full of Big Pharma began by negotiating the Medicare, which means higher prices for the elderly and the American family, while the drug is 10 billion dollars”.
Someone with good ideas are located in accordance with the executives's orders, such as reducing additional insulin costs, trying to make the state import easier. (The initial initiative of Trump's first phase) or accelerating the approval of ordinary drugs. But even though these proposals are destroyed by the White House actions, Elsee
The Food and Drug Administration has poured almost 20% of employees, which are part of the “structural adjustment” DOGE-ORCHESTATED, which is like The ability to follow To conduct potential drugs And management has Start to lay the foundation It is necessary to determine the drug tax rate imported into the United States, which may lead to higher expenses and shortages, especially for Ordinary medicine–
There is nothing about Trump's past or latest history, indicating that medical prescriptions in America are about to be significant. And if we are truly unlucky, some drugs may be more expensive than soon